PLATINUM-RESISTANT OVARIAN CANCER
Clinical trials for PLATINUM-RESISTANT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Armored immune cells take on tough ovarian cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called GB-5267, which uses a patient's own immune cells (CAR T cells) that are 'armored' with a protein (IL-18) to better target and attack ovarian cancer cells. The study includes 18 adults with platinum-resistant ovarian cancer, mean…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a common blood pressure pill boost chemo for resistant ovarian cancer?
Disease control Not yet recruitingThis study tests whether adding losartan, a blood pressure medication, to weekly paclitaxel chemotherapy can shrink tumors or slow cancer growth in people with ovarian cancer that no longer responds to platinum-based drugs. About 27 adults with advanced ovarian, fallopian tube, o…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC